Summary
Damien Marsic is a Validation Expert and AAV capsid engineer with 11 years of hands-on experience in directed evolution, gene therapy R&D, and bioinformatics. He has led cross-functional teams to develop novel AAV capsids for retinal, liver and lung targeting, including oversized genomes and immune-evasive variants, and has hands-on expertise across the full workflow from 3D-structure-informed design to Illumina/PacBio sequencing and variant barcoding. His background spans academia and industry—from postdoctoral capsid library development to senior roles at Porton Advanced, AstraZeneca and Novartis—coupling deep molecular biology skills with Python-based tools for NGS analysis. Fluent in both experimental and computational approaches, he often bridges wet-lab selection campaigns with bespoke bioinformatic pipelines, accelerating candidate discovery and biodistribution analysis. Based in Suzhou Industrial Park, he also consults on translational AAV projects, bringing a rare combination of capsid engineering creativity and validation rigor.
11 years of coding experience
19 years of employment as a software developer
DEA Biologie appliquée à la nutrition et aux bioindustries, DEA Biologie appliquée à la nutrition et aux bioindustries at Université Henri Poincaré, Nancy 1
Doctor of Philosophy (PhD) Biotechnology, Doctor of Philosophy (PhD) Biotechnology at The University of Alabama in Huntsville
Chinese, English, French, Slovenian, Spanish, Serbian, Croatian, Bosnian, Russian